Načítá se...
Cyclooxygenase-2 Inhibitor Reduces Simvastatin-Induced Bone Morphogenetic Protein-2 and Bone Formation In Vivo
OBJECTIVES: Simvastatin, a cholesterol-lowering drug, also stimulates oral bone growth when applied topically, without systemic side effects. However, the mechanisms involved in vivo are not known. We hypothesized that bone morphogenetic protein-2 (BMP-2), nitric oxide synthase (NOS) and cyclooxygen...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2014720/ https://ncbi.nlm.nih.gov/pubmed/17451547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0765.2006.00943.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|